We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Seeks to Boost Orphan Drug Development with Grant Program
FDA Seeks to Boost Orphan Drug Development with Grant Program
November 7, 2013
The FDA has awarded 15 grants totaling more than $14 million to various research organizations — and one drugmaker — to spur development of new treatments for rare diseases, the latest signal the agency wants to prime the orphan drug pipeline.